Author

Ben Ko Chi-Bun

Hong Kong Polytechnic University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alex Chun Ho Law· 1 shared Allen Ming Fai Leung· 1 shared Carol Lee· 1 shared Cherie Tsz‐Yiu Law· 1 shared Chunning Leung· 1 shared July Xi Chen· 1 shared Karen Kar Loen Chan· 1 shared Man Tong· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex Chun Ho Law

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A mutation-resolved therapeutic atlas of NRAS-mutant melanoma reveals genotype-selective response to RAS(ON) inhibition and adaptive STAT3 survival

Sai Fung Yeung, July Xi Chen, Cherie Tsz‐Yiu Law, Alex Chun Ho Law, Carol Lee, Allen Ming Fai Leung, Mary Po Ki Chau, Ben Ko Chi-Bun, Wu Yue, Man Tong, 梁开喜, William C. Cho, Michelle K.Y. Siu, Karen Kar Loen Chan, Chunning Leung, Stephen Kwok‐Wing Tsui

This paper identifies genotype-specific responses to RAS(ON) inhibitors in NRAS-mutant melanoma and shows that STAT3 inhibition enhances therapeutic efficacy.

bioRxiv · Mar 13, 2026 · PreprintCancer Biology